COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,893 Articles (22,568 medRxiv, 8,325 bioRxiv)

Most recent first Previous |  Page 2389: Articles 23881-23890  | Next

A-to-I RNA editing in SARS-COV-2: real or artifact?
Picardi, E., Mansi, L., Pesole, G.
10.1101/2020.07.27.223172 — Posted: 2020-07-27
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with an endemic human CoV
Ladner, J. T., Henson, S. N., Boyle, A. S., Engelbrektson, A. L., Fink, Z. W., Rahee, F., D'ambrozio, J., Schaecher, K. E., Stone, M., Dong, W., Dadwal, S., Yu, J., Caligiuri, M. A., Cieplak, P., Bjoras, M., Fenstad, M. H., Nordbo, S. A., Kainov, D. E., Muranaka, N., Chee, M. S., Shiryaev, S. A., Altin, J. A.
10.1101/2020.07.27.222943 — Posted: 2020-07-27
CAR Macrophages for SARS-CoV-2 Immunotherapy
Fu, W., Lei, C., Qian, K., Ma, Z., Li, T., Lin, F., Zhao, J., Hu, S.
10.1101/2020.07.26.222208 — Posted: 2020-07-27
Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
Moon, C., Sahakijpijarn, S., Koleng, J. J., Williams, R. O.
10.1101/2020.07.26.222109 — Posted: 2020-07-27
Molecular mechanisms of Cardiac Injury associated with myocardial SARS-CoV-2 infection
Liu, X., Lou, L., Zhou, L.
10.1101/2020.07.27.220954 — Posted: 2020-07-27
Targeting the endolysosomal host-SARS-CoV-2 interface by the clinically licensed antidepressant fluoxetine
Schloer, S., Brunotte, L., Goretzko, J., Mecate-Zambrano, A., Korthals, N., Gerke, V., Ludwig, S., Rescher, U.
10.1101/2020.07.27.222836 — Posted: 2020-07-27
Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals
Doddapaneni, H. V., Cregeen, S. J., Sucgang, R., Meng, Q., Qing, X., Avadhanula, V., Chao, H., Menon, V., Nicholson, E., Henke, D., Piedra, F.-A., Rajan, A., Momin, Z., Kottapalli, K., Hoffman, K. L., Sedlazeck, F. J., Metcalf, G., Piedra, P. A., Muzny, D. M., Petrosino, J. F., Gibbs, R. A.
10.1101/2020.07.27.223495 — Posted: 2020-07-27
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) Protein Inhibits Type I and III Interferon Production by Targeting RIG-I/MDA-5 Signaling
Wang, P.-H., Zheng, Y., Zhuang, M.-W., Han, L., Zhang, J., Nan, M.-L., Gao, C.
10.1101/2020.07.26.222026 — Posted: 2020-07-27 Discussion: Onsite | Offsite
Antiviral effects of miRNAs in extracellular vesicles against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and mutations in SARS-CoV-2 RNA virus
Moon, J., Park, J. H., Choi, Y., Lim, C.-W., Park, J.-M., Yu, S.-H., Kim, Y., Han, H. J., Kim, C.-H., Song, Y.-S., Kim, C.
10.1101/2020.07.27.190561 — Posted: 2020-07-27
Progenitor identification and SARS-CoV-2 infection in long-term human distal lung organoid cultures
Salahudeen, A. A., Choi, S. S., Rustagi, A., Zhu, J., de la O, S. M., Flynn, R. A., Margalef-Catala, M., Santos, A. J. M., Ju, J., Batish, A., van Unen, V., Usui, T., Zheng, G. X. Y., Edwards, C. E., Wagar, L. E., Luca, V., Anchang, B., Nagendran, M., Nguyen, K., Hart, D. J., Terry, J. M., Belgrader, P., Ziraldo, S. B., Mikkelsen, T. S., Harbury, P. B., Glenn, J. S., Garcia, K. C., Davis, M. M., Baric, R. S., Sabatti, C., Amieva, M. R., Blish, C. A., Desai, T. J., Kuo, C. J.
10.1101/2020.07.27.212076 — Posted: 2020-07-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).